ALMS
ALUMIS INC.
NASDAQ · Healthcare · Biotechnology · US
$6.34
+3.59%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 102.58x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.81x
- Price / sales
- 110.92x
- Price / cash flow
- -2.34x
Enterprise value
- Enterprise value
- $354.8M
- EV / sales
- 47.95x
- EV / EBITDA
- -0.80x
- EV / EBIT
- -0.77x
- Market cap
- $820.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026